APA (7th ed.) Citation

Santiago-Hernandez, A., Martin-Lorenzo, M., Gomez-Serrano, M., Lopez, J., Martinez, P., Vazquez, J., . . . Alvarez-Llamas, G. (2022). Early cardiorenal risk is molecularly evidenced in hypertensive subjects within the normoalbuminuria condition. Novel glycotargets for cardiovascular risk stratification. Atherosclerosis, 355, 230. https://doi.org/10.1016/j.atherosclerosis.2022.06.894

Chicago Style (17th ed.) Citation

Santiago-Hernandez, A., et al. "Early Cardiorenal Risk Is Molecularly Evidenced in Hypertensive Subjects Within the Normoalbuminuria Condition. Novel Glycotargets for Cardiovascular Risk Stratification." Atherosclerosis 355 (2022): 230. https://doi.org/10.1016/j.atherosclerosis.2022.06.894.

MLA (9th ed.) Citation

Santiago-Hernandez, A., et al. "Early Cardiorenal Risk Is Molecularly Evidenced in Hypertensive Subjects Within the Normoalbuminuria Condition. Novel Glycotargets for Cardiovascular Risk Stratification." Atherosclerosis, vol. 355, 2022, p. 230, https://doi.org/10.1016/j.atherosclerosis.2022.06.894.